4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001662579-24-000100
President & CEO gave up 5,550 shares (to pay taxes)
- President & CEO acquired 12,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hirsch Andrew President & CEO | 2024-11-07 | Option exercise | +12,500 | 227,412 | D | ||
| Hirsch Andrew President & CEO | 2024-11-07 | Shares withheld for taxes | −5,550 | $6.04 | $33,522 | 221,862 | D |
| Derivatives | |||||||
| Hirsch Andrew President & CEO | 2024-11-07 | Option exercise · Performance Restricted Stock Units | −12,500 | 35,000 | D | ||
Loading xslF345X05/wk-form4_1731446213.xml…